La colchicine réduit le risque de complications liées à la COVID-19
23. Januar 2021 01:00 ET
|
Institut de Cardiologie de Montréal (ICM)
MONTRÉAL, 23 janv. 2021 (GLOBE NEWSWIRE) -- L’Institut de Cardiologie de Montréal (ICM) annonce aujourd’hui que l’étude clinique COLCORONA a fourni des résultats cliniquement convaincants de...
Colchicine reduces the risk of COVID-19-related complications
23. Januar 2021 01:00 ET
|
Montreal Heart Institute
MONTREAL, Jan. 23, 2021 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) announced today that the COLCORONA clinical trial has provided clinically persuasive results of colchicine’s efficacy...
La colchicine réduit le risque de complications liées à la COVID-19
22. Januar 2021 22:58 ET
|
Institut de Cardiologie de Montréal (ICM)
MONTRÉAL, 22 janv. 2021 (GLOBE NEWSWIRE) -- L’Institut de Cardiologie de Montréal (ICM) annonce aujourd’hui que l’étude clinique COLCORONA a fourni des résultats cliniquement convaincants de...
Colchicine reduces the risk of COVID-19-related complications
22. Januar 2021 22:58 ET
|
Montreal Heart Institute
MONTREAL, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) announced today that the COLCORONA clinical trial has provided clinically persuasive results of colchicine’s efficacy...
New data supports development of colchicine for the prevention of acute respiratory distress syndrome
03. Dezember 2020 12:00 ET
|
Montreal Heart Institute
MONTREAL, Dec. 03, 2020 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) has announced that colchicine, a widely available low-cost drug, reduces acute lung injury (ALI), acute respiratory...
La colchicine se révèle prometteuse pour traiter à domicile les patients atteints de la COVID-19
28. November 2020 19:49 ET
|
Institut de Cardiologie de Montréal (ICM)
Montréal, 28 nov. 2020 (GLOBE NEWSWIRE) -- L’Institut de Cardiologie de Montréal (ICM) annonce aujourd’hui que l’étude clinique COLCORONA continuera de recruter des patients adultes...
Colchicine shows promise as a treatment for at-home COVID-19 patients
28. November 2020 19:49 ET
|
Montreal Heart Institute
MONTREAL, Nov. 28, 2020 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) today announced that the COLCORONA clinical trial will continue to recruit non-hospitalized adult patients with...
L'Institut de Cardiologie de Montréal (ICM) annonce que l'étude clinique COLCORONA des patients atteints de la COVID-19 a passé le test de la futilité
26. Juni 2020 21:53 ET
|
Institut de Cardiologie de Montréal (ICM)
MONTRÉAL, 26 juin 2020 (GLOBE NEWSWIRE) -- L'Institut de Cardiologie de Montréal annonce aujourd'hui que l’étude clinique COLCORONA continuera de recruter des patients adultes non-hospitalisés...
Montreal Heart Institute announces COLCORONA trial in patients with COVID-19 passes futility test in interim analysis
26. Juni 2020 21:53 ET
|
Montreal Heart Institute
MONTREAL, June 26, 2020 (GLOBE NEWSWIRE) -- Montreal Heart Institute today announced that the COLCORONA clinical trial will continue to recruit non-hospitalized adult patients with COVID-19 as...
FDA and Health Canada Approve Thermedical’s Degassed Saline to Help Reduce Risk of Stroke
16. Juni 2020 09:09 ET
|
Montreal Heart Institute
MONTREAL and WALTHAM, Mass., June 16, 2020 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) and Thermedical®, a developer of thermal-ablation systems to treat ventricular arrhythmias, today...